| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604283 | International Journal of Cardiology | 2017 | 7 Pages |
Abstract
IL-32 might be a novel predictor of adverse cardiac event in patients with HF after MI. The pro-fibrotic effect of IL-32 may contribute to adverse cardiac remodeling and progression to HF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Wanling Xuan, Weixing Huang, Ruijie Wang, Chang Chen, Yequn Chen, Yan Wang, Xuerui Tan,